CodeTitleTypeCategory
MOPEB16 Association between HIV-related factors and hypertension and diabetes among people living with HIV in CameroonPoster exhibitionCo-morbidities
MOPEB17 Renal safety parameters after switch to doravirine/islatravir (DOR/ISL 100/0.75mg) once-daily: week 48 results from 2 randomized, active-controlled phase 3 trials, MK8591A-017 (P017) and MK8591A-018 (P018)Poster exhibitionClinical complications of HIV and antiretroviral therapy
MOPEB18 A randomized controlled trial of (5R)-5-hydroxytriptolide in HIV INRs receiving ARTPoster exhibitionClinical complications of HIV and antiretroviral therapy
MOPEB19 Weight gain among people living with HIV in Zambia transitioning to dolutegravir-based antiretroviral regimens containing tenofovir alafenamide versus tenofovir disoproxil fumaratePoster exhibitionClinical complications of HIV and antiretroviral therapy
MOPEB20 Sedative drug burden is associated with concurrent physical frailty in people aging with HIV in Canada: findings from the Positive Brain Health Now Study (+BHN)Poster exhibitionHIV and ageing
MOPEB21 Disability in people living with HIV (PLWH) in Asia: a prospective multi-centre case-control studyPoster exhibitionHIV and ageing
MOPEC01 Race, place, and substance use continue to impact HIV incidence among Sexual Minority Men: active surveillance of HIV seroconversion from the UNITE Longitudinal Cohort studyPoster exhibitionEpidemiology of HIV
MOPEC02 Demographic and clinical characteristics of mpox among people living with HIV/AIDS (PLWHA) during the 2022 outbreak in Brazil: an observational studyPoster exhibitionEpidemiology of HIV
MOPEC03 Prevalence and correlates of dual mood disorders among PLHIV-PWUD in a Canadian settingPoster exhibitionEpidemiology of HIV
MOPEC04 Molecular and phylodynamic approaches to the characterisation of HIV-1 transmission: a genomic epidemiological study in Victoria, AustraliaPoster exhibitionSurveillance: Measuring the HIV epidemic
41 - 50 of 1427 items